HARTFORD, Conn. (WTNH) A Hartford Healthcare neurologist is cautiously excited about a new treatments ability to prevent memory loss in patients with Alzheimers disease.

Dr. Amy Sanders has been watching research indicating that the drug lecanemab can either slow or altogether stop cognitive decline.

The results, she said, werent surprising.

That has been the Holy Grail of Alzheimers disease pharmaceutical research for decades, so this is the first time my heart went pitty pat, when I read these announcements, Sanders said.

Lecanemab clears amyloid plaques, which are protein deposits linked to dementia.

Weve had agents that could clear amyloid plaques in the past, but we have not had the one-two punch, Sanders said. And its possible that we now have it.

The 1,800 people in the clinical trial had either a mild form of Alzheimers disease, or a pre-Alzheimers condition that is considered to be a mild cognitive impairment.

While the data wont be released until the end of November, the Alzheimers Association has called the study a major development, and said that more drugs are in the pipeline.

See the rest here:
Hartford Healthcare neurologist excited about possible new Alzheimers disease treatment - WTNH.com